Indian tech entrepreneur on mission to democratise healthcare
Friday, February 10, 2017
A leading Indian tech entrepreneur has decided to invest in a UK-based genomics data platform company to “democratise precision healthcare” and help pharmaceuticals develop targeted therapeutics. Ambarish Mitra, well known as the co-founder and CEO of Blippar – an augmented reality and computer vision based AI application platform – will invest in the Cambridge-based Global Gene Corp to bring medicine to the masses. “Global Gene Corp sits at the convergence point of genomic & life sciences, machine learning and big data technologies. They have fundamentally disrupted the business model to deliver a platform that is scalable and affordable – which is key to bringing precision medicine to the masses,” Mitra said.
Genomics seeks to sequence, assemble, and ultimately understand the function of genomes, the complete set of DNA within a single cell of an organism. The insights gained through genomics help scientists better understand disease and then develop more effective drug delivery systems and therapeutics.
The Global Gene Corp team discovered that over 60 per cent of the world’s population is almost completely unrepresented by the available genomic data – mainly of Asians and Africans.
- Health Care